1. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985; 103:1796–806.
2. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1995; 113:1144–55.
3. Paccola L, Costa RA, Folgosa MS, et al. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol. 2008; 92:76–80.
Article
4. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabeitc diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology. 2004; 111:218–24. discussion 224–5.
5. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992; 99:753–9.
Article
6. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of abdominal in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010; 33:2399–405.
7. Kim M, Lee P, Kim Y, et al. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic abdominal edema. Ophthalmologica. 2011; 226:138–44.
8. Wu PC, Lai CH, Chen CL, Kuo CN. Optical coherence abdominal patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment. J Ocul Pharmacol Ther. 2012; 28:59–64.
9. Lee K, Chung H, Park Y, Sohn J. Efficacy of intravitreal antiabdominal endothelial growth factor or steroid injection in diabetic abdominal edema according to fluid turbidity in optical coherence tomography. Korean J Ophthalmol. 2014; 28:298–305.
10. Jeon S, Lee WK. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab. Retina. 2014; 34:1606–11.
Article
11. Choi YJ, Oh IK, Oh JR, Huh K. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema. Korean J Ophthalmol. 2006; 20:205–9.
Article
12. Cellini M, Pazzaglia A, Zamparini E, et al. Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid abdominal edema. BMC Ophthalmol. 2008; 8:5.
Article
13. Jeon S, Lee WK. Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates. Clin Ophthalmol. 2014; 8:1479–86.
14. Kim HD, Kang KD, Choi KS, et al. Combined therapy with abdominal bevacizumab and posterior subtenon triamcinolone abdominal injection in diabetic macular oedema. Acta Ophthalmol. 2014; 92:e589–90.
15. Ahmadieh H, Ramezani A, Shoeibi N, et al. Intravitreal abdominal with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2008; 246:483–9.
16. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina. 2006; 26:999–1005.
Article
17. Soheilian M, Ramezani A, Bijanzadeh B, et al. Intravitreal abdominal (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina. 2007; 27:1187–95.
18. Lee YJ, Choi KS, Lee SJ. Treatment of diabetic macular edema: a comparative study. J Korean Ophthalmol Soc. 2010; 51:849–59.
Article
19. Kim HD, Choi KS, Lee SJ. Combined therapy of intravitreal abdominal and posterior subtenon triamcinolone acetonide abdominal in diabetic macular edema. J Korean Ophthalmol Soc. 2009; 50:1652–6.
20. Ciardella AP, Klancnik J, Schiff W, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol. 2004; 88:1131–6.
Article
21. Avci R, Kaderli B. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol. 2006; 244:28–35.
22. Khairallah M, Zeghidi H, Ladjimi A, et al. Primary intravitreal abdominal acetonide for diabetic massive macular hard exudates. Retina. 2005; 25:835–9.
23. Deák GG, Bolz M, Kriechbaum K, et al. Effect of retinal photo-coagulation on intraretinal lipid exudates in diabetic macular abdominal documented by optical coherence tomography. Ophthalmology. 2010; 117:773–9.